Analyzing Press Ganey (PGND) and NantHealth (NH)

NantHealth (NASDAQ: NH) and Press Ganey (NYSE:PGND) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, earnings, valuation, profitability and analyst recommendations.

Insider & Institutional Ownership

7.1% of NantHealth shares are owned by institutional investors. Comparatively, 91.9% of Press Ganey shares are owned by institutional investors. 58.0% of NantHealth shares are owned by company insiders. Comparatively, 5.1% of Press Ganey shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares NantHealth and Press Ganey’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NantHealth -225.76% -46.09% -25.23%
Press Ganey 8.69% 5.46% 3.34%

Analyst Recommendations

This is a summary of recent recommendations and price targets for NantHealth and Press Ganey, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth 0 0 4 0 3.00
Press Ganey 0 0 0 0 N/A

NantHealth currently has a consensus target price of $9.00, indicating a potential upside of 161.63%. Given NantHealth’s higher probable upside, equities research analysts clearly believe NantHealth is more favorable than Press Ganey.

Valuation & Earnings

This table compares NantHealth and Press Ganey’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NantHealth $100.38 million 3.71 -$184.10 million ($1.78) -1.93
Press Ganey N/A N/A N/A $0.51 79.41

Press Ganey has lower revenue, but higher earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Press Ganey, indicating that it is currently the more affordable of the two stocks.

Summary

Press Ganey beats NantHealth on 6 of the 10 factors compared between the two stocks.

NantHealth Company Profile

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Press Ganey Company Profile

Press Ganey Holdings, Inc. is a provider of patient experience and caregiver measurement, performance analytics and strategic advisory solutions for healthcare organizations. The Company provides its clients with a digital platform that captures the perspectives of patients, physicians, nurses and other healthcare employees and enables its clients to benchmark, analyze and manage the patient and caregiver experience. Its solutions include Patient Experience Solutions, which include Patient experience measurement, insights and advisory services; Caregiver Engagement Solutions, which include Physician, nurse and employee engagement measurement, insights and advisory services; Clinical and Quality Solutions, which include nursing quality indicators, patient reported outcome measures, core measures and eMeasures, and Consulting Solutions, which include patient safety and care reliability, patient experience improvement, process flow, advanced analytics and insights and cultural alignment.

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply